retatrutide ada 2025 results New Phase 3 data just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving historically associated with bariatric surgery. A few important caveats Retatrutide: The Unapproved Drug America

In clinical trials , patients experienced nearly 15% weight loss

Certain formulations are FDA-approved to lower the risk of serious cardiovascular events, such as heart attacks and strokes, in adults with heart disease who are overweight or obese

Usually, the greater the starting body weight and the greater the calorie deficit, the greater the weight loss at least initially, says Rothberg

This information is power

GLP-1 Weight Loss Services Near Me: Roxborough Clinic in Silver Spring, MD Struggling to achieve your weight loss goals

But if youre looking at whats safe, available, and tolerable to take right now, Zepbound seems to be the clear winner